News
-
-
-
-
-
-
-
-
PRESS RELEASE
EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma: Preliminary Q2 2025 figures exceed capital market expectations
SCHOTT Pharma AG & Co. KGaA exceeds Q2 2025 expectations with EUR 252m revenues, EUR 72m EBITDA, and 28.6% EBITDA margin, maintaining full-year guidance. Detailed results on May 15, 2025 -
-